SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-004564
Filing Date
2024-01-08
Accepted
2024-01-08 17:22:27
Documents
6

Document Format Files

Seq Description Document Type Size
1 DFAN14A d871430ddfan14a.htm DFAN14A 46478
2 GRAPHIC g871430g0109015950203.jpg GRAPHIC 2774
3 GRAPHIC g871430g0109020044830.jpg GRAPHIC 31700
4 GRAPHIC g871430g0109020044986.jpg GRAPHIC 54367
5 GRAPHIC g871430g0109020045153.jpg GRAPHIC 35897
6 GRAPHIC g871430g0109020045327.jpg GRAPHIC 34868
  Complete submission text file 0001193125-24-004564.txt   268831
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Subject) CIK: 0001990550 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-56600 | Film No.: 24521106
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)